<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The outcome of <z:e sem="disease" ids="C0262428" disease_type="Disease or Syndrome" abbrv="">collagen vascular diseases</z:e> after treatment with plasmapheresis was studied in 9 patients with <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e> (PN), in 2 patients with Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WG</z:e>), in 1 patient with allergic granulomatous angitis (AGA), and in 20 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) associated with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>Improvement after treatment with plasmapheresis was observed in 41.7% of the patients with PN, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">WG</z:e>, and AGA </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, with the exception of 1 patient with <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and 1 patient with <z:hpo ids='HP_0000083'>renal failure</z:hpo>, <z:hpo ids='HP_0000001'>all</z:hpo> of the clinical manifestations, including <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, <z:hpo ids='HP_0004418'>thrombophlebitis</z:hpo>, lung infarction, and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortions</z:e> in the SLE patients with APS, improved after plasmapheresis </plain></SENT>
<SENT sid="3" pm="."><plain>Plasmapheresis is thought to be an influential strategy of treatment for patients with <z:e sem="disease" ids="C0262428" disease_type="Disease or Syndrome" abbrv="">collagen vascular diseases</z:e> </plain></SENT>
</text></document>